*Phase I & Pharmacokinetics

Honorem can assist our partners in the design and delivery of the early-phase clinical development.
We understand the challenges of rapidly shifting factors, involving regulatory requirements, study design strategies and project optimization.

Honorem provides expert pharmacokinetic (PK) and pharmacodynamic (PD) support, in accordance with international and APAC regional regulatory standards. We offer consulting, analysis and custom tailored support to all Phase I and PK Studies.